TY - JOUR
T1 - Update on sebaceous neoplasia
T2 - the morphologic spectrum and molecular genetic drivers of carcinoma
AU - Tetzlaff, Michael T.
AU - North, Jeffrey
AU - Esmaeli, Bita
N1 - Publisher Copyright:
© 2019
PY - 2019/3
Y1 - 2019/3
N2 - Tumors with sebaceous differentiation represent a challenge to diagnose, classify and occasionally to treat. The histopathologic spectrum of sebaceous neoplasia includes sebaceous adenoma, sebaceoma, and sebaceous carcinoma, while sebaceous hyperplasia represents hyperplasia of benign sebaceous glands surrounding a hair follicle. While often recognizable on morphologic grounds alone, sebaceous lineage also be informed by the application of immunohistochemical studies, including antibodies for adipophilin and Factor XIIIa (AC-1A1 clone). Sebaceous tumors are important to recognize given the relationship to the Muir-Tore autosomal dominant cancer predisposition syndrome. However, although it is well accepted that a sebaceous tumor might exhibit defects in mismatch repair, whether such a defect is related to germline defects in mismatch repair genes (or are due to somatically acquired alterations limited to the tumor cells) remains a critical clinical question with significant implications for the patient. Finally, recently published molecular studies have elaborated a molecular-genetic framework by which to understand the drivers of sebaceous carcinomas arising in different anatomic locations.
AB - Tumors with sebaceous differentiation represent a challenge to diagnose, classify and occasionally to treat. The histopathologic spectrum of sebaceous neoplasia includes sebaceous adenoma, sebaceoma, and sebaceous carcinoma, while sebaceous hyperplasia represents hyperplasia of benign sebaceous glands surrounding a hair follicle. While often recognizable on morphologic grounds alone, sebaceous lineage also be informed by the application of immunohistochemical studies, including antibodies for adipophilin and Factor XIIIa (AC-1A1 clone). Sebaceous tumors are important to recognize given the relationship to the Muir-Tore autosomal dominant cancer predisposition syndrome. However, although it is well accepted that a sebaceous tumor might exhibit defects in mismatch repair, whether such a defect is related to germline defects in mismatch repair genes (or are due to somatically acquired alterations limited to the tumor cells) remains a critical clinical question with significant implications for the patient. Finally, recently published molecular studies have elaborated a molecular-genetic framework by which to understand the drivers of sebaceous carcinomas arising in different anatomic locations.
KW - DNA mismatch repair
KW - Muir-Tore syndrome
KW - sebaceoma
KW - sebaceous adenoma
KW - sebaceous carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85060892753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060892753&partnerID=8YFLogxK
U2 - 10.1016/j.mpdhp.2019.01.001
DO - 10.1016/j.mpdhp.2019.01.001
M3 - Review article
AN - SCOPUS:85060892753
SN - 1756-2317
VL - 25
SP - 102
EP - 109
JO - Diagnostic Histopathology
JF - Diagnostic Histopathology
IS - 3
ER -